Goldberg Y. Paul

VP of Clinical Development at XENE

Sold, on record
$197k
Dollars the filings state
Form 4 sales
1
Latest Sep 24, 2015
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • XENEXenon Pharmaceuticals Inc.VP of Clinical Development

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale XENEUnusual
    Sep 24, 2015 2015

    Sold 22,149 shares at $8.88 ($197k)

    Goldberg Y. Paul, VP of Clinical Development

    Sold 78.7% of holdings ($250k position)6,000 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (1)

Form 144 notices and Form 4 sales by Goldberg Y. Paul
Source
Sep 24, 2015Sep 24, 2015XENEVP of Clinical DevelopmentForm 4 sale22,149$197k78.7%UnusualSEC